Next Article in Journal
Leveraging Multimodal Foundation Models in Biliary Tract Cancer Research
Previous Article in Journal
Performance of a Deep Learning Reconstruction Method on Clinical Chest–Abdomen–Pelvis Scans from a Dual-Layer Detector CT System
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Electron Density and Effective Atomic Number of Normal-Appearing Adult Brain Tissues: Age-Related Changes and Correlation with Myelin Content

1
Department of Radiology, Kagoshima University Graduate School of Medical and Dental Sciences, 8-35-1 Sakuragaoka, Kagoshima 890-8544, Japan
2
Philips GmbH Market DACH, Röntgenstr. 22, 22335 Hamburg, Germany
3
Philips Healthcare, Nahum Het Street 16, Haifa 3100202, Israel
*
Author to whom correspondence should be addressed.
Tomography 2025, 11(9), 95; https://doi.org/10.3390/tomography11090095 (registering DOI)
Submission received: 17 July 2025 / Revised: 18 August 2025 / Accepted: 21 August 2025 / Published: 25 August 2025
(This article belongs to the Section Brain Imaging)

Abstract

Objectives: Few studies have reported in vivo measurements of electron density (ED) and effective atomic number (Zeff) in normal brain tissue. To address this gap, dual-energy computed tomography (DECT)-derived ED and Zeff maps were used to characterize normal-appearing adult brain tissues, evaluate age-related changes, and investigate correlations with myelin partial volume (Vmy) from synthetic magnetic resonance imaging (MRI). Materials and Methods: Thirty patients were retrospectively analyzed. The conventional computed tomography (CT) value (CTconv), ED, Zeff, and Vmy were measured in the normal-appearing gray matter (GM) and white matter (WM) regions of interest. Vmy and DECT-derived parameters were compared between WM and GM. Correlations between Vmy and DECT parameters and between age and DECT parameters were analyzed. Results: Vmy was significantly greater in WM than in GM, whereas CTconv, ED, and Zeff were significantly lower in WM than in GM (all p < 0.001). Zeff exhibited a stronger negative correlation with Vmy (ρ = −0.756) than CTconv (ρ = −0.705) or ED (ρ = −0.491). ED exhibited weak to moderate negative correlations with age in nine of the 14 regions. In contrast, Zeff exhibited weak to moderate positive correlations with age in nine of the 14 regions. CTconv exhibited negligible to insignificant correlations with age: Conclusions: This study revealed distinct GM–WM differences in ED and Zeff along with opposing age-related changes in these quantities. Therefore, myelin may have substantially contributed to the lower Zeff observed in WM, which underlies the GM–WM contrast observed on non-contrast-enhanced CT.

1. Introduction

In normal adult brains, the gray matter (GM) exhibits higher computed tomography (CT) attenuation (measured in Hounsfield units) than the white matter (WM). Loss of the gray–white contrast is a key non-contrast-enhanced CT finding of hyperacute ischemic stroke [1,2]. Brooks et al. [3] attributed this native gray–white contrast on CT to the differences in the chemical composition of the two brain compartments. With higher lipid content and lower water content, the WM includes more carbon, which is lower in atomic number (i.e., 6), and less oxygen, which is higher in atomic number (i.e., 8), than the GM. Hence, photoelectric X-ray absorption is smaller in the WM, resulting in lower CT value in the WM than in the GM. Recently, dual-energy CT (DECT) has become widely available in clinical practice. DECT enables the imaging of electron density (ED) and effective atomic number (Zeff), which represents a weighted average of the atomic numbers of a material’s constituent elements [4,5,6,7,8,9,10]. However, publications on the ED and Zeff in the normal human brain obtained using clinical CT scanners are limited. To the best of our knowledge, age-related changes have not been reported. With the clinical implementation of photon-counting detector CT underway, normal brain ED and Zeff values, as well as their age-related changes, may serve as valuable fundamental data for future investigations into the potential of CT-derived parameters for the quantitative evaluation of cerebral diseases. Myelin is a key contributor to the compositional differences between the GM and WM. Myelin is a lipid-rich material that covers neuronal axons and serves as an electric insulator [11,12]. It enables fast and efficient signal transmission via saltatory nerve conduction [11]. Myelin has a strong impact on magnetic resonance imaging (MRI) contrast. For example, myelin is associated with the characteristic properties of longitudinal and transverse relativity and magnetization transfer [13,14,15]. Taking advantage of the characteristic MR properties of myelin, a multiparametric model for myelin content based on T1, T2, and proton density (PD) values derived from synthetic MRI data were proposed [16]. The quantitative evaluation of myelin partial volume (Vmy) based on this model was validated through a correlation with measurement in cadaveric brain tissue [17] and has been used to assess various brain diseases [18,19,20,21,22]. To date, no studies have examined the correlation between Zeff and ED derived from DECT and Vmy derived from synthetic MRI. We hypothesized that myelin exhibits a major impact on the atomic number difference, which results in gray–white contrast on non-contrast-enhanced brain CT; thus, Zeff is strongly correlated with Vmy. The purposes of this study were to characterize ED and Zeff in normal-appearing adult brain tissues and their age-related changes in vivo using a clinical DECT scanner and to clarify the correlations between DECT-derived ED or Zeff and Vmy derived from synthetic MRI.

2. Materials and Methods

2.1. Study Population

This retrospective study was approved by the Institutional Review Board of our institution on 30 July 2024 (approval number 230267). The requirement for informed consent was waived considering the retrospective and noninvasive nature of the study. All procedures were conducted according to the principles outlined in the Declaration of Helsinki.
In total, 112 consecutive patients who underwent DECT and synthetic MRI as part of the evaluation of intracranial diseases between April 2021 and March 2023 at our hospital were considered for inclusion. The inclusion criteria were as follows: (1) age older than 18 years and (2) interval between DECT and synthetic MRI within 30 days. The exclusion criteria were as follows: (1) present or past history of neurological or psychiatric diseases, (2) history of neurosurgical intervention, chemotherapy, or brain radiation therapy; (3) poor quality of CT and MR images; (4) presence of supratentorial intra-axial lesions, such as infarctions, contusion, and tumors, on MRI; (5) severity of cerebral hyperintensity on fluid-attenuated inversion recovery (FLAIR) images of grade 3 or higher either or both in the periventricular or deep WM according to the classification by Fazekas et al. [23]; (6) presence of ≥4; microbleeds on susceptibility-weighted images; (7) presence of midline shift or extensive brain edema; and (8) presence of ventricular enlargement suspected of hydrocephalus. A board-certified radiologist with 30 years of experience in neuroradiology assessed the exclusion criteria. The images and clinical information of the patients were obtained from the picture archiving and communication system and medical charts in our hospital.

2.2. CT Imaging

CT images were obtained using a multidetector row DECT system (IQon Spectral CT; Philips Healthcare, Best, The Netherlands), which was equipped with a dual-layer spectral detector and a single X-ray source, constantly enabling the acquisition of high- and low-energy projection data and retrospective dual-energy data analysis. The imaging parameters were as follows: tube voltage, 120 kVp; effective tube current–exposure time product, 400 mAs; detector-row configuration, 64 × 0.625 mm; gantry rotation time, 0.4 s; and pitch, 0.36. The reconstruction slice thickness was 1.0 mm. The volume CT dose index (CTDIvol) was 67.7 mGy; the mean dose–length product (DLP) was 1513.0 mGy·cm (range, 1349–1824 mGy·cm). Because a dual-layer detector system was used, no additional radiation exposure was required to obtain dual-energy data. The CT systems were inspected every three months by Philips service engineers, and underwent daily phantom-based quality control checks performed by the facility’s radiologic technologists.
Conventional 120-kVp CT images (CTconv) and quantitative ED and Zeff maps were generated using a dedicated workstation (IntelliSpace Portal; Philips Healthcare) [24]. ED was expressed in percent ED relative to water (%EDW).

2.3. MR Imaging

MRI scans were obtained using a 3.0-T system (Achieva dStream; Philips Healthcare, Best, The Netherlands) with a 32-channel head receiving coil. Synthetic MRI data were acquired as a part of routine brain MRI examination using a two-dimensional axial method with quantification of relaxation times and PD by multi-echo acquisition of saturation-recovery using turbo spin-echo readout pulse sequence. It used two echo times (13 and 100 ms) and four delay times (110, 440, 1210, and 2530 ms) to generate eight actual and eight imaginary images. Other parameters were as follows: repetition time, 3600 ms; flip angle, 90°; sensitivity encoding factor, 2.2; field of view, 230 × 230 mm2; matrix resolution, 315 × 258; echo-train length, 10; slice thickness, 5.0 mm; gap, 1.0 mm; 24 slices; and scan time, 5 min and 24 s. Vmy was mapped using SyMRI (version 19.3; SyMRI, Linköping, Sweden). This software also generated synthetic T1-weighted images, T2-weighted images, PD, and FLAIR images in addition to quantitative maps of T1, T2, PD, and Vmy [16,25]. In addition to synthetic MRI, conventional MR images were acquired, including pre-contrast 2D FLAIR and 3D susceptibility-weighted images. Table 1 lists the imaging parameters of those images.

2.4. Image Analysis

For each patient, CT images (CTconv, ED, and Zeff) were registered with the corresponding synthetic T2WI using Statistical Parametric Mapping 12 (revision 7219; Functional Imaging Laboratory, UCL Queen Square Institute of Neurology, London, UK; https://www.fil.ion.ucl.ac.uk/spm/ (accessed on 22 August 2025)). Two independent radiologists with 9 and 18 years of experience in diagnostic radiology (TH and MN, respectively) measured the regions of interest (ROIs) using ImageJ (version 1.52a; National Institutes of Health, Bethesda, MD, USA; https://imagej.net/ij/ (accessed on 22 August 2025)). Ovoid ROIs (area 15 mm2) were manually placed on the synthetic PD images in 12 GM (bilateral caudate heads, putamina, globus pallidi, and lateral, medial, and dorsal thalami) and 14 WM (bilateral frontal, parietal, temporal, and occipital lobes, bilateral centrum semiovales [CSs] and posterior limbs of the internal capsule [PLIC], and genu [GCC] and splenium [SCC] of the corpus callosum) regions and cerebrospinal fluid (CSF) in the bilateral lateral ventricles (Figure 1, Table 2). ROIs were set carefully to exclude partial volume averaging at tissue boundaries. Areas with calcification on CT and abnormal signal intensity on FLAIR or susceptibility weighted imaging (SWI) were avoided. The ROIs were copied onto the corresponding maps of Vmy, CTconv, ED, and Zeff, in which the ROI mean parametric values were obtained.

2.5. Statistical Analysis

Statistical analyses were performed using Statistical Package for the Social Sciences (version 28; IBM Corp.; Armonk, NY, USA; https://www.ibm.com/products/spss-statistics, (accessed on 23 August 2025)). p-values <0.05 were used to denote statistical significance. Interobserver agreement for the ROI measurement was evaluated using the intraclass correlation coefficient (ICC). ICC values of 0.00–0.20, 0.21–0.40, 0.41–0.60, 0.61–0.80, and 0.81–1.00 indicate poor, fair, moderate, good, and excellent agreements, respectively. Furthermore, Bland–Altman analysis was used to report the bias and 95% limits of agreement between the two observers. For parameters with no significant interobserver differences, the averaged values from the two observers were used for further analyses. Comparisons between numerical variables were performed using the Mann–Whitney U test or unpaired t-test, as appropriate. The Shapiro–Wilk normality test was used to check the normality of the data. Spearman’s correlation coefficient (ρ) was used to analyze correlations between the Vmy and CT parameters and between patient age and CT parameters and Vmy. For the latter, data from the right and left ROIs were averaged, except for those from the GCC and SCC. Because of the limited patient age range, quadratic fitting was not performed. Correlation coefficients of 0.00–0.19, 0.20–0.39, 0.40–0.69, 0.70–0.89, and 0.90–1.00 indicated negligible to very weak, weak, moderate, strong, and very strong correlations, respectively (modified from Schober et al. [26]). Simple and multiple regression analyses were performed to generate a mathematical model of Vmy using CT-derived parameters, with the coefficient of determination (R2) used to assess the goodness of fit—that is, the proportion of variance in Vmy explained by the model.

3. Results

3.1. Participants

Figure 2 presents the patient selection flowchart. Finally, 30 patients were eligible for the analysis (Table 3). The patients’ ages ranged from 35 to 84 years. Twenty-two (73%) patients were female. The most frequent indication for imaging examinations was extra-axial tumors (23 patients, 77%), of which 20 (67%) were pathologically proven to be meningiomas.

3.2. Interobserver Agreement of the Measurements

Table 4 presents the agreement between the two observers. The ICCs between the two readers were 0.975 for Vmy, 0.873 for CTconv, 0.884 for ED, and 0.948 for Zeff, indicating excellent agreement. The Bland–Altman plot revealed reasonable agreement for each parameter. No obvious bias was observed for any parameter. Figure 3 presents the Bland–Altman plot for each imaging parameter.

3.3. Comparison of Vmy and CT Parameters Between the WM and GM

Figure 4 presents representative images of Vmy, CTconv, ED, and Zeff. Table 5 present the values of Vmy and CT parameters in the WM, GM, and CSF. Vmy was significantly greater in the WM (35.6 ± 4.7%) than in the GM (14.0 ± 8.1%) (p < 0.001), whereas CTconv, ED, and Zeff were significantly lower in the WM (25.9 ± 2.5 HU, 102.8 ± 0.2%EDW, and 7.2 ± 0.0, respectively) than in the GM (33.4 ± 3.2 HU, 103.2 ± 0.2%EDW, and 7.3 ± 0.1, respectively) (each p < 0.001). CTconv and ED were significantly lower in the CSF (4.1 ± 2.4 HU and 100.2 ± 0.2%EDW, respectively) than in both the WM and GM (each p < 0.001). Zeff was significantly greater in the CSF (7.3 ± 0.1) than in the WM (p < 0.001) but was similar to that in the GM.

3.4. Correlation Between Vmy and CT Parameters and Regression Analyses

Table 6 and Figure 5 present the correlation between Vmy and CT parameters. CTconv, ED, and Zeff were negatively correlated with Vmy (each p < 0.001) when all WM and GM ROIs were included in the analysis. The strongest correlation was observed for Zeff (ρ = −0.756), followed by CTconv (ρ = −0.705). The correlation between Vmy and ED was moderate (ρ = −0.491). The three CT parameters were also negatively correlated with Vmy in the GM: the correlation was moderate for Zeff (ρ = −0.478), weak for CTconv (ρ = −0.379), and negligible to very weak for ED (ρ = −0.151). In the WM, only ED was weakly and positively correlated with Vmy (ρ = 0.202).
Table 7 summarizes the regression analysis results. Simple regression analysis for all ROIs revealed that Zeff had the highest model fit (R2 = 0.606) among the three CT parameters. In the multiple regression analysis, Zeff and ED were included as independent variables and increased the model’s explanatory power (R2 = 0.675).

3.5. Correlation Between Patient Age and Vmy or CT Parameters

Table 8 presents Spearman’s correlation coefficients between patient age and imaging parameters. Vmy exhibited a significant negative correlation with age in 10 of 14 regions. A stronger correlation was noted in WM regions, including the frontal (ρ = −0.741) and parietal (ρ = −0.719) lobes and CS (ρ = −0.701), followed by moderate correlations in the occipital (ρ = −0.678) and temporal WM (ρ = −0.649), globus pallidus (ρ = −0.646), lateral thalamus (ρ = −0.605), PLIC (ρ = −0.552), GCC (ρ = −0.413), and medial thalamus (ρ = −0.378). The correlation between patient age and CTconv was either negligible to very weak or weak without statistical significance in all regions. ED exhibited a weak to moderate negative correlation with age in nine of the 14 regions. Statistical significance was noted in three WM regions (i.e., CS, PLIC, and occipital lobe; ρ ranged from −0.411 to −0.450). In contrast, Zeff exhibited a weak to moderate positive correlation with patient age in nine of the 14 regions. A significant moderate correlation was observed in the WM of the occipital (ρ = 0.549), temporal (ρ = 0.437), and frontal (ρ = 0.405) lobes. Figure 6 presents age-related changes in Vmy, CTconv, ED, and Zeff in the WM regions.

4. Discussion

This study revealed that, in normal-appearing adult brain tissues, CTconv, ED, and Zeff were significantly lower in the WM than in the GM. CTconv was strongly and negatively correlated with Vmy derived from synthetic MRI, and Zeff derived from DECT exhibited a stronger correlation with Vmy than CTconv and ED. These results support our hypothesis that myelin exhibits a major impact on the atomic number difference, which results in the gray–white contrast on non-contrast-enhanced brain CT. ED and Zeff exhibited negative and positive correlations with age, respectively, particularly in the WM regions, whereas CTconv exhibited no obvious age-related changes in both the GM and WM.
Although DECT has been widely used in clinical practice, reports on ED and Zeff in the cerebral GM, WM, and CSF of living human brains are limited. The mean ED was significantly lower in the WM than in the GM; however, the difference was smaller (approximately 0.4%EDW) than the difference between the WM and CSF (approximately 2.6%EDW). These findings are consistent with those of a previous study on the calculated ED values of the respective tissues [27], although their absolute values were slightly greater than ours. The mean Zeff was significantly lower in the WM than in the GM, and their difference was approximately 0.1 (1.5%). This is also qualitatively consistent with the report of the calculated results [27]. The lack of a significant difference in Zeff between the CSF and GM appears to contradict the values previously reported by Hünemohr et al. [27] (7.45 for the CSF and 7.34 for the cerebral GM), which were calculated with six major elements (i.e., H, C, N, O, Ca, and P). However, when trace elements (i.e., Na, S, Cl, and K) were considered, the calculated Zeff values in the CSF and GM were similar [24,28], supporting our findings.
X-ray absorption includes photoelectric and Compton components. Brook et al. [3] reported that the gray–white contrast on non-contrast-enhanced CT originates from the photoelectric component, which is influenced by the atomic number of the sample; however, there is no difference in the Compton component between the two compartments. Based on a quantitative simulation using the reported values, the gray–white difference in the atomic number was attributable to the relative abundance of carbon and the relative paucity of oxygen in the WM, which has more lipid and less water content than the GM [3]. Myelin mainly comprises a complex lipid called sphingolipid. These substances possess many carbon atoms in their carbon chains. The strong negative correlation between Zeff and Vmy revealed in this study may be caused by such chemical structural features of myelin.
In our results, the mean ED was slightly lower in the WM than in the GM. Because the EDs of water and lipid are substantially lower than those of brain tissues [27], the ED of brain tissues can be affected by both the lipid and water content. The lower water content in the WM than in the GM does not explain the lower ED in the WM. Thus, it is likely due to the relative abundance of lipid content in the WM versus the GM.
Our regression analysis revealed that Zeff explained a greater proportion of the variance between Vmy and ED or CTconv. Thus, Zeff is a potential CT imaging marker of myelin in normal-appearing adult brains. In the multiple regression analysis, a combination of Zeff and ED improved the explanatory power of the model (R2 = 0.689) compared with Zeff alone (R2 = 0.617). As predicted by the theory proposed by Brooks et al. [3], the Zeff of brain tissues is influenced by both the lipid and water content. We speculate that the improvement in modeling of Vmy by adding ED to Zeff could be attributable to the correction of the water content. Thus, in normal-appearing adult brains, the myelin content can be estimated with some degree of accuracy by combining Zeff and ED.
Vmy exhibited negative correlations with age throughout the GM and WM, more strongly in the cerebral WM. This is in accordance with a previous synthetic MRI study by Hagiwara et al. [29] and likely represents age-related demyelination. CTconv exhibited no obvious correlation with age, which is consistent with the findings in several previous studies [30,31]. In contrast, ED exhibited weak to moderate negative correlations and Zeff exhibited weak to moderate positive correlations with age, mainly in the WM. The positive correlation of Zeff with age can be attributable to the synergetic effects of age-related demyelination and axonal loss and the accompanying increase in interstitial water. The negative correlation of ED with age indicates increased water content. The lack of age-related changes in CTconv may be attributable to the opposing age-related effects of ED and Zeff on CTconv. Thus, ED and Zeff can detect age-related WM changes that are undetectable by the conventional CT value.
DECT parameters acquired on clinical CT scanners correlated significantly with Vmy. This association suggests that DECT may serve as a noninvasive, adjunctive tool for evaluating disorders characterized by myelin loss, including neurodegenerative and demyelinating conditions traditionally assessed with MRI. Compared with MRI, CT is less costly, faster, and operationally simpler; moreover, DECT remains feasible when MRI is contraindicated or difficult (e.g., in patients with non–MR-conditional metallic implants, severe claustrophobia, or in pediatric and older patients for whom sedation is challenging), and may function as an alternative in selected scenarios. Furthermore, the result that ED and Zeff correlate with age even within normal-appearing white matter on MRI suggests that these measures may enable earlier detection of age-related changes in brain parenchyma. Given their quantitative nature, establishing age-stratified reference ranges for ED and Zeff could improve the sensitivity for detecting abnormalities.
This study has several limitations that should be considered. First, because of radiation exposure, healthy volunteers were not scanned. The number of subjects was small because only patients who underwent both DECT and synthetic MRI were included and patients with any supratentorial lesions on MRI that could profoundly affect the measurements of the imaging parameters were excluded. Younger patients were not included because CT imaging is typically avoided for those who are more sensitive to radiation exposure than older adults. It consequently limited the age range (≥35 years); these circumstances denied us the opportunity to observe continuing myelination in young adults. The strong female predominance in the patient group of this study is likely related to the fact that many patients had meningiomas. This bias prevented the sex-specific analysis of the imaging parameters. Finally, this study did not examine the relationship between ED or Zeff and the water content in brain tissue. As mentioned earlier, in addition to lipid content, water content has been postulated as a contributor to Zeff difference between the GM and WM [3]. Using a synthetic MRI-based approach, we clarified the correlation between Zeff and lipid-rich myelin. However, images of water content were not available in our retrospective analysis. In future studies, the inclusion of imaging techniques sensitive to water content, for example, based on diffusion MRI [32], could help clarify the complete picture of the relationship between CT-derived parameters (Zeff and ED) and brain tissue composition.

5. Conclusions

In conclusion, this study confirmed the differences in ED and Zeff between the GM and WM using a clinical DECT scanner. Moreover, a strong negative correlation was observed between Zeff and myelin content derived from synthetic MRI, suggesting that abundant carbon in myelin is a dominant contributor to lower Zeff in the WM than in the GM that generates the gray–white contrast on non-contrast-enhanced CT images of adults. Unlike CTconv, ED and Zeff exhibited opposing age-related changes mainly in the WM, which may offer a novel opportunity for CT-based evaluation of WM aging.

Author Contributions

Conceptualization, T.Y.; methodology, K.T. and F.E.; software, G.P. and E.L.; formal analysis, T.H., M.N. and M.G.; data curation, K.K., T.N. and J.K.; writing—original draft preparation, T.H.; writing—review and editing, F.K., K.T., F.E., G.P., E.L., M.N., M.G., K.K., T.N., J.K., R.N., R.Y. and T.Y.; visualization, R.N., R.Y. and F.K.; project administration, T.Y.; All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

The study was conducted in accordance with the Declaration of Helsinki, and approved by the Clinical Research Ethics Committee of Kagoshima University of 230267 on 30 July 2024.

Informed Consent Statement

Patient consent was waived due to its retrospective and non-invasive nature.

Data Availability Statement

The original data presented in the study are openly available in FigShare at [https://doi.org/10.6084/m9.figshare.29595734].

Conflicts of Interest

Gregor Pahn was employed by Philips GmbH Market DACH, and Eran Langzam was employed by Philips Healthcare. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Abbreviations

CSCentrum semiovales
CSFCerebrospinal fluid
CTComputed tomography
CTconvConventional CT value
CTDIvolVolume CT dose index
DECTDual-energy computed tomography
DLPDose–length product
EDElectron density
GCGenu of the corpus callosum
FLAIRFluid-attenuated inversion recovery
GMGray matter
ICCIntraclass correlation coefficient
MRIMagnetic resonance imaging
PDProton density
PLICPosterior limb of the internal capsule
QRAPMASTERQuantification of relaxation times and PD by multi-echo acquisition of saturation-recovery using turbo spin-echo readout
R2Coefficient of determination
ROIRegions of interest
SCSplenium of the corpus callosum
SWISusceptibility weighted imaging
VmyMyelin partial volume
WMWhite matter
ZeffEffective atomic number
%EDWPercent electron density relative to water

References

  1. Truwit, C.L.; Barkovich, A.J.; Gean-Marton, A.; Hibri, N.; Norman, D. Loss of the insular ribbon: Another early CT sign of acute middle cerebral artery infarction. Radiology 1990, 176, 801–806. [Google Scholar] [CrossRef]
  2. Moulin, T.; Cattin, F.; Crépin-Leblond, T.; Tatu, L.; Chavot, D.; Piotin, M.; Viel, J.F.; Rumbach, L.; Bonneville, J.F. Early CT signs in acute middle cerebral artery infarction: Predictive value for subsequent infarct locations and outcome. Neurology 1996, 47, 366–375. [Google Scholar] [CrossRef]
  3. Brooks, R.A.; Di Chiro, G.; Keller, M.R. Explanation of cerebral white-gray contrast in computed tomography. J. Comput. Assist. Tomogr. 1980, 4, 489–491. [Google Scholar] [CrossRef]
  4. Nakajima, S.; Ito, H.; Mitsuhashi, T.; Kubo, Y.; Matsui, K.; Tanaka, I.; Fukui, R.; Omori, H.; Nakaoka, T.; Sakura, H.; et al. Clinical application of effective atomic number for classifying non-calcified coronary plaques by dual-energy computed tomography. Atherosclerosis 2017, 261, 138–143. [Google Scholar] [CrossRef]
  5. Kaichi, Y.; Tatsugami, F.; Nakamura, Y.; Baba, Y.; Iida, M.; Higaki, T.; Kiguchi, M.; Tsushima, S.; Yamasaki, F.; Amatya, V.J.; et al. Improved differentiation between high- and low-grade gliomas by combining dual-energy CT analysis and perfusion CT. Medicine 2018, 97, e11670. [Google Scholar] [CrossRef]
  6. Nagano, H.; Takumi, K.; Nakajo, M.; Fukukura, Y.; Kumagae, Y.; Jinguji, M.; Tani, A.; Yoshiura, T. Dual-energy CT-derived electron density for diagnosing metastatic mediastinal lymph nodes in non-small cell lung cancer: Comparison with conventional CT and FDG PET/CT findings. Am. J. Roentgenol. 2022, 218, 66–74. [Google Scholar] [CrossRef] [PubMed]
  7. Zhao, W.; Shen, S.; Ke, T.; Jiang, J.; Wang, Y.; Xie, X.; Hu, X.; Tang, X.; Han, D.; Chen, J. Clinical value of dual-energy CT for predicting occult metastasis in central neck lymph nodes of papillary thyroid carcinoma. Eur. Radiol. 2024, 34, 16–25. [Google Scholar] [CrossRef]
  8. Wang, Y.; Hu, H.; Ban, X.; Jiang, Y.; Su, Y.; Yang, L.; Shi, G.; Yang, L.; Han, R.; Duan, X. Evaluation of quantitative dual-energy computed tomography parameters for differentiation of parotid gland tumors. Acad. Radiol. 2024, 31, 2027–2038. [Google Scholar] [CrossRef] [PubMed]
  9. Jeong, J.; Ham, S.; Shim, E.; Kim, B.H.; Kang, W.Y.; Kang, C.H.; Ahn, K.S.; Lee, K.C.; Choi, H. Electron density dual-energy CT can improve the detection of lumbar disc herniation with higher image quality than standard and virtual non-calcium images. Eur. Radiol. 2024, 34, 7334–7346. [Google Scholar] [CrossRef]
  10. Aizaz, M.; Bierens, J.; Gijbels, M.J.J.; Schreuder, T.H.C.M.L.; van Orshoven, N.P.; Daemen, J.H.C.; Mess, W.H.; Flohr, T.; van Oostenbrugge, R.J.; Postma, A.A.; et al. Differentiation of atherosclerotic carotid plaque components with dual-energy computed tomography. Investig. Radiol. 2025, 60, 508–516. [Google Scholar] [CrossRef] [PubMed]
  11. Stadelmann, C.; Timmler, S.; Barrantes-Freer, A.; Simons, M. Myelin in the central nervous system: Structure, function, and pathology. Physiol. Rev. 2019, 99, 1381–1431. [Google Scholar] [CrossRef]
  12. Poitelon, Y.; Kopec, A.M.; Belin, S. Myelin fat facts: An overview of lipids and fatty acid metabolism. Cells 2020, 9, 812. [Google Scholar] [CrossRef]
  13. Natu, V.S.; Gomez, J.; Barnett, M.; Jeska, B.; Kirilina, E.; Jaeger, C.; Zhen, Z.; Cox, S.; Weiner, K.S.; Weiskopf, N.; et al. Apparent thinning of human visual cortex during childhood is associated with myelination. Proc. Natl. Acad. Sci. USA 2019, 116, 20750–20759. [Google Scholar] [CrossRef]
  14. Schmierer, K.; Tozer, D.J.; Scaravilli, F.; Altmann, D.R.; Barker, G.J.; Tofts, P.S.; Miller, D.H. Quantitative magnetization transfer imaging in postmortem multiple sclerosis brain. J. Magn. Reson. Imaging 2007, 26, 41–51. [Google Scholar] [CrossRef]
  15. Alonso-Ortiz, E.; Levesque, I.R.; Pike, G.B. MRI-based myelin water imaging: A technical review. Magn. Reson. Med. 2015, 73, 70–81. [Google Scholar] [CrossRef]
  16. Warntjes, M.; Engström, M.; Tisell, A.; Lundberg, P. Modeling the presence of myelin and edema in the brain based on multi-parametric quantitative MRI. Front. Neurol. 2016, 7, 16. [Google Scholar] [CrossRef]
  17. Warntjes, J.B.M.; Persson, A.; Berge, J.; Zech, W. Myelin detection using rapid quantitative MR imaging correlated to macroscopically registered Luxol fast blue-stained brain specimens. Am. J. Neuroradiol. 2017, 38, 1096–1102. [Google Scholar] [CrossRef] [PubMed]
  18. Hagiwara, A.; Warntjes, M.; Hori, M.; Andica, C.; Nakazawa, M.; Kunishima Kumamaru, K.; Abe, O.; Aoki, S. SyMRI of the brain: Rapid quantification of relaxation rates and proton density, with synthetic MRI, automatic brain segmentation, and myelin measurement. Investig. Radiol. 2017, 52, 647–657. [Google Scholar] [CrossRef] [PubMed]
  19. Park, M.; Moon, Y.; Han, S.-H.; Kim, H.K.; Moon, W.-J. Myelin loss in white matter hyperintensities and normal-appearing white matter of cognitively impaired patients: A quantitative synthetic magnetic resonance imaging study. Eur. Radiol. 2019, 29, 4914–4921. [Google Scholar] [CrossRef] [PubMed]
  20. Andica, C.; Hagiwara, A.; Hori, M.; Haruyama, T.; Fujita, S.; Maekawa, T.; Kamagata, K.; Takemura Yoshida, M.; Suzuki, M.; Sugano, H.; et al. Aberrant myelination in patients with Sturge-Weber syndrome analyzed using synthetic quantitative magnetic resonance imaging. Neuroradiology 2019, 61, 1055–1066. [Google Scholar] [CrossRef]
  21. Parlak, S.; Coban, G.; Gumeler, E.; Karakaya, J.; Soylemezoglu, F.; Tezer, I.; Bilginer, B.; Saygi, S.; Oguz, K.K. Reduced myelin in patients with isolated hippocampal sclerosis as assessed by SyMRI. Neuroradiology 2022, 64, 99–107. [Google Scholar] [CrossRef]
  22. Ladopoulos, T.; Matusche, B.; Bellenberg, B.; Heuser, F.; Gold, R.; Lukas, C.; Schneider, R. Relaxometry and brain myelin quantification with synthetic MRI in MS subtypes and their associations with spinal cord atrophy. NeuroImage Clin. 2022, 36, 103166. [Google Scholar] [CrossRef]
  23. Fazekas, F.; Chawluk, J.B.; Alavi, A.; Hurtig, H.I.; Zimmerman, R.A. MR signal abnormalities at 1.5 T in Alzheimer’s dementia and normal aging. Am. J. Roentgenol. 1987, 149, 351–356. [Google Scholar] [CrossRef] [PubMed]
  24. Hua, C.-H.; Shapira, N.; Merchant, T.E.; Klahr, P.; Yagil, Y. Accuracy of electron density, effective atomic number, and iodine concentration determination with a dual-layer dual-energy computed tomography system. Med. Phys. 2018, 45, 2486–2497. [Google Scholar] [CrossRef]
  25. Warntjes, J.B.M.; Dahlqvist Leinhard, O.; West, J.; Lundberg, P. Rapid Magnetic Resonance Quantification on the Brain: Optimization for Clinical Usage. Magn. Reson. Med. 2008, 60, 320–329. [Google Scholar] [CrossRef] [PubMed]
  26. Schober, P.; Boer, C.; Schwarte, L.A. Correlation coefficients: Appropriate use and interpretation. Anesth. Anal. 2018, 126, 1763–1768. [Google Scholar] [CrossRef]
  27. Hünemohr, N.; Paganetti, H.; Greilich, S.; Jäkel, O.; Seco, J. Tissue decomposition from dual energy CT data for MC based dose calculation in particle therapy. Med. Phys. 2014, 41, 061714. [Google Scholar] [CrossRef]
  28. Woodard, H.Q.; White, D.R. The composition of body tissues. Br. J. Radiol. 1986, 59, 1209–1219. [Google Scholar] [CrossRef] [PubMed]
  29. Hagiwara, A.; Fujimoto, K.; Kamagata, K.; Murata, S.; Irie, R.; Kaga, H.; Someya, Y.; Andica, C.; Fujita, S.; Kato, S.; et al. Age-related changes in relaxation times, proton density, myelin, and tissue volumes in adult brain analyzed by 2-dimensional quantitative synthetic magnetic resonance imaging. Investig. Radiol. 2021, 56, 163–172. [Google Scholar] [CrossRef]
  30. Schwartz, M.; Creasey, H.; Grady, C.L.; DeLeo, J.M.; Frederickson, H.A.; Cutler, N.R.; Rapoport, S.I. Computed tomographic analysis of brain morphometrics in 30 healthy men, aged 21 to 81 years. Ann. Neurol. 1985, 17, 146–157. [Google Scholar] [CrossRef]
  31. Stafford, J.L.; Albert, M.S.; Naeser, M.A.; Sandor, T.; Garvey, A.J. Age-related differences in computed tomographic scan measurements. Arch. Neurol. 1988, 45, 409–415. [Google Scholar] [CrossRef] [PubMed]
  32. Pasternak, O.; Sochen, N.; Gur, Y.; Intrator, N.; Assaf, Y. Free water elimination and mapping from diffusion MRI. Magn. Reson. Med. 2009, 62, 717–730. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Regions of interests (ROIs) placed on synthetic proton density images. In the frontal lobe, the ROIs were placed anterior to the frontal horn of the lateral ventricle. In the temporal lobe, the ROIs were placed in the WM lateral to the inferior horn of the lateral ventricles. In the occipital lobe, the ROIs were positioned in the WM near the occipital pole. In the parietal lobe, the ROIs were placed in the WM at the level of the centrum semiovale. Within the thalamus, three ROIs were placed bilaterally in the presumed medial nuclei, posterior region (pulvinar), and lateral nuclei (excluding the pulvinar). The ROIs in the lateral ventricle were positioned anteriorly in the body to avoid choroid plexus.
Figure 1. Regions of interests (ROIs) placed on synthetic proton density images. In the frontal lobe, the ROIs were placed anterior to the frontal horn of the lateral ventricle. In the temporal lobe, the ROIs were placed in the WM lateral to the inferior horn of the lateral ventricles. In the occipital lobe, the ROIs were positioned in the WM near the occipital pole. In the parietal lobe, the ROIs were placed in the WM at the level of the centrum semiovale. Within the thalamus, three ROIs were placed bilaterally in the presumed medial nuclei, posterior region (pulvinar), and lateral nuclei (excluding the pulvinar). The ROIs in the lateral ventricle were positioned anteriorly in the body to avoid choroid plexus.
Tomography 11 00095 g001
Figure 2. Flow of subject selection [23].
Figure 2. Flow of subject selection [23].
Tomography 11 00095 g002
Figure 3. Bland–Altman plots for the myelin partial volume (a), conventional CT value (b), electron density (c), and effective atomic number (d) measurements.
Figure 3. Bland–Altman plots for the myelin partial volume (a), conventional CT value (b), electron density (c), and effective atomic number (d) measurements.
Tomography 11 00095 g003
Figure 4. Representative images of the myelin partial volume (a), conventional CT (b), electron density (c), and effective atomic number (d).
Figure 4. Representative images of the myelin partial volume (a), conventional CT (b), electron density (c), and effective atomic number (d).
Tomography 11 00095 g004
Figure 5. Correlation of the conventional CT value (a), electron density (b), and effective atomic number (c) with the myelin partial volume.
Figure 5. Correlation of the conventional CT value (a), electron density (b), and effective atomic number (c) with the myelin partial volume.
Tomography 11 00095 g005
Figure 6. Age-related changes in the myelin partial volume (a), conventional CT value (b), electron density (c), and effective atomic number (d).
Figure 6. Age-related changes in the myelin partial volume (a), conventional CT value (b), electron density (c), and effective atomic number (d).
Tomography 11 00095 g006
Table 1. Imaging parameters of conventional MRI sequences.
Table 1. Imaging parameters of conventional MRI sequences.
ParameterFLAIRSWI
PlaneAxialAxial
TR (ms)900031
TE (ms)1207.2/13.4/19.6/25.8
TI (ms)2700-
FA (°) (Refocus °)180 (120)17
Bandwidth (Hz/pixel)322255
Number of signal averages14
Turbo factor15-
Acceleration factor1.67
FOV (mm)230 × 230230 × 230
Matrix (frequency × phase)511 × 511767 × 767
Thickness (mm)51
Slice number24150
Acquisition time (s)162116
FA, flip angle; FOV, field of view; TE, echo time; TR, repetition time.
Table 2. Locations of Regions of Interest (ROIs).
Table 2. Locations of Regions of Interest (ROIs).
White Matter (14 Regions)Gray Matter (12 Regions)
      Right frontal lobe      Right caudate head
      Left frontal lobe      Left caudate head
      Right temporal lobe      Right putamen
      Left temporal lobe      Left putamen
      Right occipital lobe      Right globus pallidus
      Left occipital lobe      Left globus pallidus
      Right parietal lobe      Right medial thalamus
      Left parietal lobe      Left medial thalamus
      Right centrum semiovale      Right dorsal thalamus
      Left centrum semiovale      Left dorsal thalamus
      Right posterior limb of the internal capsule      Right lateral thalamus
      Left posterior limb of the internal capsule      Left lateral thalamus
      Genu of the corpus callosum      
      Splenium of the corpus callosum      
Cerebrospinal fluid (2 regions)
      Right lateral ventricle      
      Left lateral ventricle
Table 3. Patient characteristics.
Table 3. Patient characteristics.
CharacteristicValue
Age
   Median67.5 years
   Range35–84 years
    30–391 (3%)
    40–496 (20%)
    50–594 (13%)
    60–695 (17%)
    70–798 (27%)
    80–896 (20%)
Sex
   Female22 (73%)
Indication of imaging studies
   Extra-axial tumor23 (77%)
   Infratentorial lesion7 (23%)
Fazekas score
   Periventricular
    09 (30%)
    116 (53%)
    25 (17%)
   Deep white matter
    017 (57%)
    112 (40%)
    21 (3%)
Number of microbleeds
    025 (83%)
    13 (10%)
    21 (3%)
    31 (3%)
Table 4. Interobserver agreement.
Table 4. Interobserver agreement.
Intraclass Correlation Coefficients (95% CI)Bland–Altman Analysis
Mean Differences (95% CI)Lower Limit (95% CI)Upper Limit (95% CI)
Myelin partial volume0.975 (0.971, 0.979)−0.398 (−0.595, −0.201)−5.890 (−6.226, −5.553)5.093 (4.756, 5.430)
Conventional CT value0.873 (0.855, 0.889)−0.174 (−0.3458, −0.000)−4.963 (−5.256, −4.670)4.615 (4.321, 4.908)
Electron density0.884 (0.868, 0.899)−0.013 (−0.023, −0.260)−0.276 (−0.297, −0.260)0.249 (0.233, 0.265)
Effective atomic number0.948 (0.940, 0.955)−0.000 (−0.002, 0.001)−0.046 (−0.049, −0.043)0.044 (0.043, 0.048)
95% CI, 95% confidence intervals.
Table 5. Myelin Partial Volume, Conventional CT Value, Electron Density, and Effective Atomic Number of White Matter, Gray Matter, and Cerebrospinal Fluid.
Table 5. Myelin Partial Volume, Conventional CT Value, Electron Density, and Effective Atomic Number of White Matter, Gray Matter, and Cerebrospinal Fluid.
WM (n = 420)GM (n = 360)CSF (n = 60)p Value for Difference
WM vs. GMGM vs. CSFCSF vs. WM
Myelin partial volume (%)35.6 ± 4.714.0 ± 8.10.0 ± 0.0<0.001<0.001<0.001
Conventional CT value (HU)25.9 ± 2.533.4 ± 3.24.1 ± 2.4<0.001<0.001<0.001
Electron density (%EDW)102.8 ± 0.2103.2 ± 0.2100.2 ± 0.2<0.001<0.001<0.001
Effective atomic number7.2 ± 0.07.3 ± 0.17.3 ± 0.1<0.0010.742<0.001
CSF, cerebrospinal fluid; GM, gray matter; HU, Hounsfield unit; WM, white matter; %EDW, percent electron density relative to water. p values were obtained using the Mann–Whitney U test.
Table 6. Correlations between Myelin Partial Volume and CT parameters.
Table 6. Correlations between Myelin Partial Volume and CT parameters.
All (WM + GM) (n = 780)WM (n = 420)GM (n = 360)
ρpρpρp
Conventional CT value−0.705<0.0010.1040.033−0.379<0.001
Electron density−0.491<0.0010.202<0.001−0.1510.004
Effective atomic number−0.756<0.001−0.0980.044−0.478<0.001
GM, gray matter; WM, white matter. Correlation was evaluated using Spearman’s rank correlation coefficient.
Table 7. Simple and multiple regression analyses of Myelin Partial Volume using CT parameters as independent variables.
Table 7. Simple and multiple regression analyses of Myelin Partial Volume using CT parameters as independent variables.
All (WM + GM)
(n = 780)
WM (n = 420)GM (n = 360)
R2pR2pR2p
Simple regression analysisConventional CT value0.565<0.0010.0100.0400.145<0.001
Electron density0.253<0.0010.036<0.0010.0270.002
Effective atomic number0.606<0.0010.0050.1330.252<0.001
Multiple regression analysisElectron density
+
Effective atomic number
0.675<0.0010.036<0.0010.290<0.001
WM, white matter; GM, gray matter; R2, coefficient of determination.
Table 8. Correlations between patients’ age and Myelin Partial Volume or CT parameters.
Table 8. Correlations between patients’ age and Myelin Partial Volume or CT parameters.
Myeline Partial VolumeConventional CT ValueElectron DensityEffective Atomic Number
ρpρpρpρp
Caudate nucleus−0.3240.0810.0200.915−0.1190.5320.1840.331
Putamen−0.2760.139−0.1210.525−0.2050.2760.2830.130
Globus Pallidus−0.646<0.0010.1370.471−0.1660.3800.2750.142
Lateral thalamus−0.605<0.001−0.0010.995−0.1240.5150.1800.341
Medial thalamus−0.3780.0400.0470.807−0.3030.1030.1980.295
Dorsal thalamus−0.3340.0710.3080.0980.0340.8580.2110.264
Posterior limb of internal capsule−0.5520.002−0.2630.160−0.4130.0230.1490.433
Splenium of the corpus callosum0.0080.965−0.0090.964−0.1060.5790.1770.348
Genu of the corpus callosum−0.4130.0230.1650.383−0.2040.2800.3310.074
Centrum semiovale−0.701<0.001−0.2620.162−0.4500.0130.2640.158
Frontal lobe WM−0.741<0.0010.0160.931−0.2510.1810.4050.026
Occipital lobe WM−0.678<0.001−0.1480.436−0.4110.0240.5490.002
Temporal lobe WM−0.649<0.001−0.1990.293−0.3230.0820.4370.016
Parietal lobe WM−0.719<0.0010.0840.658−0.3050.1010.3080.098
WM, white matter. Correlation was evaluated using Spearman’s rank correlation coefficient.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Hasegawa, T.; Nakajo, M.; Gohara, M.; Kamimura, K.; Nakano, T.; Kamizono, J.; Takumi, K.; Ejima, F.; Pahn, G.; Langzam, E.; et al. Electron Density and Effective Atomic Number of Normal-Appearing Adult Brain Tissues: Age-Related Changes and Correlation with Myelin Content. Tomography 2025, 11, 95. https://doi.org/10.3390/tomography11090095

AMA Style

Hasegawa T, Nakajo M, Gohara M, Kamimura K, Nakano T, Kamizono J, Takumi K, Ejima F, Pahn G, Langzam E, et al. Electron Density and Effective Atomic Number of Normal-Appearing Adult Brain Tissues: Age-Related Changes and Correlation with Myelin Content. Tomography. 2025; 11(9):95. https://doi.org/10.3390/tomography11090095

Chicago/Turabian Style

Hasegawa, Tomohito, Masanori Nakajo, Misaki Gohara, Kiyohisa Kamimura, Tsubasa Nakano, Junki Kamizono, Koji Takumi, Fumitaka Ejima, Gregor Pahn, Eran Langzam, and et al. 2025. "Electron Density and Effective Atomic Number of Normal-Appearing Adult Brain Tissues: Age-Related Changes and Correlation with Myelin Content" Tomography 11, no. 9: 95. https://doi.org/10.3390/tomography11090095

APA Style

Hasegawa, T., Nakajo, M., Gohara, M., Kamimura, K., Nakano, T., Kamizono, J., Takumi, K., Ejima, F., Pahn, G., Langzam, E., Nakanosono, R., Yamagishi, R., Kanzaki, F., & Yoshiura, T. (2025). Electron Density and Effective Atomic Number of Normal-Appearing Adult Brain Tissues: Age-Related Changes and Correlation with Myelin Content. Tomography, 11(9), 95. https://doi.org/10.3390/tomography11090095

Article Metrics

Back to TopTop